Skip to main content

Table 4 Median, minimum and maximum values of cholesteryl ester (CE) species in patients with PCSK9 levels below and above the median level. *P < 0.05, ** P < 0.01

From: Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosis

PCSK9 (ng/mL) and CE species (μmol/L) SVP PCSK9 below the median level
(16 patients)
SVP PCSK9 above the median level
(15 patients)
P-value
  Median Min Max Median Min Max  
PCSK9 101.7 9.4 148.2 211.1 156.8 1362.3 **
CE 14:0 15.3 7.0 28.6 15.3 5.2 25.0  
CE 15:0 5.1 2.3 11.8 4.4 1.6 7.6  
CE 16:1 110.3 43.8 213.5 94.5 37.3 200.5  
CE16:0 256.4 100.4 418.9 177.7 71.4 285.5 *
CE18:3 21.5 12.2 61.6 21.4 6.5 40.5  
CE 18:2 839.7 385.5 1817.4 611.3 248.6 1200.1  
CE 18:1 381.2 168.1 672.9 307.3 105.2 452.8  
CE 18:0 5.6 3.1 21.7 6.1 2.3 13.8  
CE 20:5 8.9 3.4 18.9 4.7 2.3 8.8 **
CE 20:4 123.3 34.9 214.4 54.9 23.1 102.9 **
CE 20:3 12.1 3.5 35.5 8.8 3.5 15.6  
CE 20:2 0.9 0.4 2.9 0.7 0.0 1.6  
CE 20:1 0.6 0.3 2.8 0.5 0.2 1.9  
CE 20:0 0.8 0.5 1.5 0.7 0.6 1.1  
CE 22:6 6.4 2.1 14.8 3.9 1.9 8.9 **
CE 22:5 1.3 0.3 2.9 0.9 0.5 2.6  
CE 22:4 0.5 0.2 1.6 0.4 0.0 1.3 *
CE 22:1 0.4 0.2 1.4 0.3 0.0 0.7  
\